We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
Topics Covered
- Airway inflammation
- Type 2 airway inflammation
- Leukotrienes
- Leukocytes and cytokines
- Peptido-leukotrienes
Links
Series:
Categories:
Therapeutic Areas:
External Links
- Slide 5- Access Medicine: Harrison's Principles of Internal Medicine, 21st edition
- Slide 5- HIV.gov | CD4 T Lymphocyte
- Slide 5- McGraw Hill | AccessPharmacy
- Slide 7- Access Pharmacy: Lipids: The Eicosanoids: Prostaglandins, Leukotrienes, and Thromboxanes
- Slide 7- Access Medicine: Pulmonary Pharmacology
Talk Citation
Boylan, P. (2025, September 30). Theophylline and anti-leukotrienes for the treatment of airway allergic diseases: airway inflammation [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved November 12, 2025, from https://doi.org/10.69645/HVNX8527.Export Citation (RIS)
Publication History
- Published on September 30, 2025
Financial Disclosures
- Prof. Paul Boylan has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
Theophylline and anti-leukotrienes for the treatment of airway allergic diseases: airway inflammation
Published on September 30, 2025
11 min
Other Talks in the Series: Redox Signaling - Chemical Principles
Transcript
Please wait while the transcript is being prepared...
0:00
Welcome. My name is Paul Boylan.
I am faculty at
the University of
Oklahoma Health Sciences
College of Pharmacy
in Oklahoma City.
Today we'll be
discussing the topics of
Theophylline and
Anti-Leukotrienes for
the Treatment of Airway
Allergic Disorders.
0:18
This presentation will
occur in three parts.
Our intro and Part I will
cover airway inflammation.
The second component
will discuss
the medication theophylline in
the class of medications
the methylxanthines.
Then Part III we'll
discuss another
medication, montelukast,
one of the leukotriene
receptor antagonists
and updated evidence
on these medications.
0:44
Without further ado,
let's jump into
Part I and discuss
airway inflammation.
0:50
Before we take a deep dive
into airway immunology,
we should have an
introductory discussion
on essential terms that
you must be familiar with.
There are three terms that
I've placed for
you on this slide;
leukocytes, cytokines,
and interleukin.
Many of you are
likely familiar with
the stem cell line that
stem cells differentiate into
myeloid and lymphoid lines.
Common myeloid cells
include red blood cells,
platelets and then
those granulocytes.
The most common
granulocytes that
we'll talk about
throughout this course
of presentations will be
the eosinophils
and the basophils.
Compared to the lymphoid line
within the adaptive
immune response,
those will include our
B and T lymphocytes.
The lymphocytes and
the granulocytes
both together make
up the leukocytes.
These are blood cells
that are made in
the marrow and then circulate
throughout the body.
Not to be confused
with cytokines.
Although leukocytes
and cytokines
both contain that cyto prefix.
You will see that cytokines
are a little bit different.
These are smaller-sized
proteins and these are
communication
proteins that help to
network and transmit signals
between different cells.
The last component herein
will be the interleukins
and interleukins are a
subtype of the cytokines.
These interleukins are cytokines
that are made by
those leukocytes.
It could be any of
those that we've
previously discussed,
the granulocytes or
the lymphocytes,
and those cytokines will
then act on one another to
serve as messengers between
these inflammatory mediators.
Hide